508 filings
Page 7 of 26
8-K
uuxmm1i 56fc4m05
7 Nov 18
Alnylam Pharmaceuticals Reports Third Quarter 2018 Financial Results and Highlights Recent Period Activity
8:16am
8-K
4u8c jp88
10 Oct 18
Departure of Directors or Certain Officers
4:31pm
8-K
si7eha8r2 6kgfh8
2 Oct 18
Entry into a Material Definitive Agreement
4:31pm
CT ORDER
fub6 jp7k0
12 Sep 18
Confidential treatment order
12:00am
8-K
x8nnbynw 79
17 Aug 18
Entry into a Material Definitive Agreement
4:31pm
8-K
nv1qy kmpa
10 Aug 18
ONPATTROâ„¢ (patisiran) for the Treatment of the Polyneuropathy of Hereditary
3:45pm
S-8 POS
2jsppjemk dg2
2 Aug 18
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
v9dg lbnl35lfc8pa5i
2 Aug 18
Registration of securities for employees (post-effective amendment)
5:20pm
S-8 POS
sijzp70wxgz3d6 gb
2 Aug 18
Registration of securities for employees (post-effective amendment)
5:18pm
S-8 POS
5hifn8p87dy
2 Aug 18
Registration of securities for employees (post-effective amendment)
5:14pm
S-8
t18058cpqx7dci
2 Aug 18
Registration of securities for employees
5:10pm
8-K
vk34bc pbqu1wf
2 Aug 18
Alnylam Pharmaceuticals Reports Second Quarter 2018 Financial Results and Highlights Recent Period Activity
8:15am
CT ORDER
ecw08
5 Jun 18
Confidential treatment order
4:50pm
8-K
rqa4p9
15 May 18
Departure of Directors or Certain Officers
12:00am
8-K
8agvf3xbwcos t1gk9yb
3 May 18
Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
n6yq8dvj596hos8ddh
20 Apr 18
Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade
12:00am
8-K
nl2ks5f
3 Apr 18
Entry into a Material Definitive Agreement
12:00am